Abordagem clÍnica e agravos a saúde por bactérias resistentes: Sthaphylococcus Aureus (MRSA)
Nenhuma Miniatura disponível
Data
2023-12
Tipo de documento
Monografia
Título da Revista
ISSN da Revista
Título de Volume
Área do conhecimento
Ciências da Saúde
Modalidade de acesso
Acesso aberto
Editora
Autores
SA, Brenda Roveglia Peixoto Sa
ALVES, Leilane de Souza e Silva
Orientador
BARRETO, Anna Léa
Coorientador
CASTRO
Resumo
Bacterial resistance is one of the most pressing public health issues of the 21st century. According to research by the World Health Organization (WHO), multidrug-resistant bacteria will kill more than 10 million people per year in 2050, equivalent to one death every 3 seconds and more deaths from multidrug resistant victims than from cancer. Staphylococcus aureus is a gram-positive bacteria, its morphology is composed of coccus, non-perfect spherical structures, in irregular arrangements, also known for being grouped together like a “bunch of grapes”. S. aureus is present in the human microbiota and can be located on the surface of the skin and nasal cavities, but it is considered an opportunistic pathogen, and in contact with the bloodstream, it can cause a series of health complications. The main diseases caused by S. aureus are pimples, boils, pneumonia, meningitis, bacteremia, endocarditis, toxic shock syndrome, osteomyelitis,
septicemia and more. As a result of the indiscriminate use of antibiotics in recent years, S. aureus has become resistant to almost all antibiotics, making the treatment of these infections increasingly difficult. In the current scenario, S. aureus is a bacteria that presents highly virulence and resistance to antibiotics, being a concern for the community. But raising public awareness of the issue and creating new drugs for the treatment, can be a hope for the future of the human race to not to succumb to multidrug-resistant bacteria
Palavras-chave
Staphylococcus aureus, Staphylococcus aureus MRSA, Bacterial resistance, Awareness, Prevention, New drugs